Medicare Enrolled

Dr. Joseph Coney, M.D.

Ophthalmology · Beachwood, OH
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3401 ENTERPRISE PKWY, Beachwood, OH 44122
2168315700
In practice since 2006 (20 years)
NPI: 1528007101 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Coney from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Coney? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Coney

Dr. Joseph Coney is an ophthalmology specialist in Beachwood, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Coney performed 44,379 Medicare services across 3,418 unique beneficiaries.

Between the years covered by Open Payments, Dr. Coney received a total of $844,265 from 31 pharmaceutical and/or device companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Coney is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 1% volume in OH $844,265 industry payments

Medicare Practice Summary

Medicare Utilization ↗
44,379
Medicare services
Top 1% in OH for ophthalmology
3,418
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,219 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
33,180 $29 $76
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,024 $28 $78
Aflibercept eye injection (Eylea) 1,890 $691 $1,798
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
1,710 $120 $308
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,654 $91 $271
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
1,433 $61 $179
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
588 $82 $242
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
518 $159 $400
Injection, ranibizumab, 0.1 mg 297 $185 $482
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
243 $25 $72
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
185 $50 $305
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
172 $18 $48
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
158 $11 $32
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
152 $112 $325
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
99 $1,768 $4,712
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
54 $97 $259
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
11 $855 $2,184
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
11 $102 $286
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$844,265
Total received (2018-2024)
Avg $120,609/year across 7 years
Top 1% in OH for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
883
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$536,282 (63.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$239,962 (28.4%)
Other
Charitable contributions, space rental, and other categories
$42,512 (5.0%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$19,722 (2.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,787 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$164,391
2023
$146,857
2022
$188,086
2021
$115,543
2020
$47,616
2019
$132,317
2018
$49,456

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Apellis Pharmaceuticals, Inc.
$54,219
Regeneron Healthcare Solutions, Inc.
$36,540
Genentech USA, Inc.
$29,271
Genentech, Inc.
$22,191
Astellas Pharma US Inc
$9,531
Alimera Sciences, Inc.
$8,731
ABBVIE INC.
$2,805
F. Hoffmann-La Roche AG
$549
ANI Pharmaceuticals, Inc.
$189
Bausch & Lomb Americas Inc.
$156
Dutch Ophthalmic, USA
$133
Harrow Eye, LLC
$28
Coherus Biosciences Inc.
$26
Sandoz Inc.
$22
Top 3 companies account for 73.0% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$158,681
Apellis Pharmaceuticals, Inc.
$120,556
Regeneron Healthcare Solutions, Inc.
$109,981
Novartis Pharmaceuticals Corporation
$97,439
Genentech, Inc.
$65,455
US Retina LLC
$62,234
Alimera Sciences, Inc.
$46,323
Allergan, Inc.
$37,938
Allergan Inc.
$37,861
Astellas Pharma US Inc
$31,729
ABBVIE INC.
$18,782
Novartis Pharma AG
$17,738
Roche Products Limited
$13,968
NOVARTIS PHARMACEUTICALS CORPORATION
$11,612
NotalVision
$3,796
Bausch & Lomb, a division of Bausch Health US, LLC
$3,108
AbbVie Inc.
$2,868
Dutch Ophthalmic, USA
$1,331
Bausch & Lomb Americas Inc.
$748
F. Hoffmann-La Roche AG
$549
Coherus Biosciences Inc.
$325
Alcon Vision LLC
$316
EyePoint Pharmaceuticals US, Inc.
$236
ANI Pharmaceuticals, Inc.
$189
Carl Zeiss Meditec, Inc.
$140
Sun Pharmaceutical Industries Inc.
$125
Mallinckrodt LLC
$125
Biogen, Inc.
$46
Harrow Eye, LLC
$28
Sandoz Inc.
$22
VYERA PHARMACEUTICALS, LLC
$17
Top 3 companies account for 46.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · CIRRUS HD-OCT · Cequa · Cimerli · Constellation · DEXYCU · Daraprim · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · ForeseeHome · IHEEZO · ILUVIEN · Iluvien · Izervay · Lucentis · Luxor · MACUGEN · NGENUITY · Non-Covered Product · OZURDEX · PROLENSA · PURIFIED CORTROPHIN GEL · SUSVIMO · SYFOVRE · Susvimo · Syfovre · VABYSMO · VISUDYNE · VYZULTA · Vabysmo · XIPERE · Xolair · YUTIQ · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for ophthalmology in OH.

Looking for an ophthalmology specialist in Beachwood?
Compare ophthalmologists in the Beachwood area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
153
Per 100K population
12.2
County median income
$62,823
Nearest hospital
SOUTH POINTE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Coney is a mixed practice specialist, with above-average Medicare volume (top 1% in OH), with speaking/promotional industry engagement in the top 1% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Coney experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Coney performed 33,180 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Coney receive payments from pharmaceutical companies?
Yes. Dr. Coney received a total of $844,265 from 31 companies across 883 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Coney's costs compare to other ophthalmologists in Beachwood?
Dr. Coney's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Coney) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →